デフォルト表紙
市場調査レポート
商品コード
1477410

デジタル糖尿病管理市場- 世界の産業規模、シェア、動向、機会、予測、製品タイプ別、最終用途別、地域別、競合別、2019年~2029年

Digital Diabetes Management Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented by Product, By Type, By End Use, and By Region, Competition, 2019-2029F

出版日: | 発行: TechSci Research | ページ情報: 英文 183 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.10円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

デジタル糖尿病管理市場- 世界の産業規模、シェア、動向、機会、予測、製品タイプ別、最終用途別、地域別、競合別、2019年~2029年
出版日: 2024年05月06日
発行: TechSci Research
ページ情報: 英文 183 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

世界のデジタル糖尿病管理市場は、2023年に146億米ドルと評価され、予測期間では2029年までCAGR 9.30%で成長すると予測されています。

デジタル糖尿病管理とは、モバイルアプリ、ウェアラブルデバイス、ソフトウェアプラットフォーム、データ分析などのデジタル技術を使用して、糖尿病を監視、追跡、管理することを指します。糖尿病は、体内のグルコース(糖分)処理に影響を及ぼし、血糖値が高くなる慢性疾患です。効果的な糖尿病管理には、血糖値の注意深いモニタリング、投薬管理、ライフスタイルの調整、ヘルスケアプロバイダーとの定期的なコミュニケーションが必要です。デジタルソリューションは、個人がより積極的にケアに参加できるようなツールや洞察を提供することで、この管理プロセスに革命をもたらしました。糖尿病の世界の有病率は着実に増加しており、効果的で利便性の高い糖尿病管理ソリューションへの需要が高まっていました。デジタルツールは、糖尿病の管理を強化し、より良い健康結果をもたらす方法を提供しました。

市場概要
予測期間 2025-2029
2023年の市場規模 146億米ドル
2029年の市場規模 249億5,000万米ドル
CAGR 2024-2029 9.30%
急成長セグメント 持続血糖モニタリングシステム
最大市場 北米

ウェアラブルデバイス、センサー、モバイルアプリ、データ分析などのテクノロジーの急速な進歩が、革新的なデジタル糖尿病管理ソリューションの開発を促進しています。これらの技術は、より優れた洞察、リアルタイムのモニタリング、患者に合わせた推奨を提供しました。糖尿病とその管理に対する患者・ヘルスケア専門家双方の意識の高まりが、デジタルソリューションの採用を後押ししていました。人々は、自分の状態をモニターし管理するためのより包括的で便利な方法を求めていました。ヘルスケア業界は個別化医療に向かっており、デジタル糖尿病管理ソリューションは、オーダーメイドのケアを提供する上で重要な役割を果たしていました。これらのソリューションは、個々のデータを分析して、個人に合った治療計画や推奨事項を提供することができました。デジタルソリューションは、糖尿病の動向、治療効果、患者の行動に関する洞察を得るために使用できる豊富なデータを収集しました。このデータ主導型のアプローチにより、ヘルスケアプロバイダーは十分な情報に基づいた意思決定と治療計画の調整が可能になった。

主な市場促進要因

技術の進歩

個別化医療へのシフト

患者エンゲージメントの向上

主な市場課題

公平性とアクセシビリティ

相互運用性の問題

主な市場動向

モバイルアプリとソフトウェアソリューション

セグメント別インサイト

製品別インサイト

タイプ別インサイト

地域別インサイト

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界のデジタル糖尿病管理市場におけるCOVID-19の影響

第5章 顧客の声

第6章 世界のデジタル糖尿病管理市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • 製品別(スマート血糖測定器、持続血糖測定システム、スマートインスリンペン、スマートインスリンポンプ、アプリ)
    • タイプ別(ウェアラブルデバイス、ハンドヘルドデバイス)
    • 最終用途別(病院、家庭、診断センター)
    • 地域別
    • 企業別(2023年)
  • 市場マップ

第7章 アジア太平洋地域のデジタル糖尿病管理市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • 製品別
    • タイプ別
    • 用途別
    • 国別
  • アジア太平洋地域国別分析
    • 中国
    • インド
    • オーストラリア
    • 日本
    • 韓国

第8章 欧州デジタル糖尿病管理市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • 製品別
    • タイプ別
    • 用途別
    • 国別
  • 欧州国別分析
    • フランス
    • ドイツ
    • スペイン
    • イタリア
    • 英国

第9章 北米デジタル糖尿病管理市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • 製品別
    • タイプ別
    • 用途別
    • 国別
  • 北米:国別分析
    • 米国
    • メキシコ
    • カナダ

第10章 南米のデジタル糖尿病管理市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • 製品別
    • タイプ別
    • 用途別
    • 国別
  • 南米:国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第11章 中東・アフリカのデジタル糖尿病管理市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • 製品別
    • タイプ別
    • 用途別
    • 国別
  • MEA:国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第12章 市場力学

  • 促進要因
  • 課題

第13章 市場動向と発展

  • 最近の動向
  • 製品上市
  • 合併・買収

第14章 世界のデジタル糖尿病管理市場SWOT分析

第15章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第16章 PESTLE分析

第17章 競合情勢

  • Abbott Laboratories Inc.
  • Medtronic plc
  • F. Hoffmann-La Roche Ltd.
  • Bayer AG
  • Lifescan, Inc.
  • Dexcom, Inc.
  • Sanofi SA
  • Insulet Corporation
  • Ascensia Diabetes Care Holdings Ag
  • B Braun Melsungen AG

第18章 戦略的提言

第19章 調査会社・免責事項

目次
Product Code: 24041

Global Digital Diabetes Management Market was valued at USD 14.60 billion in 2023 and is anticipated to grow in the forecast period with a CAGR of 9.30% through 2029. Digital diabetes management refers to using digital technologies, such as mobile apps, wearable devices, software platforms, and data analytics, to monitor, track, and manage diabetes. Diabetes is a chronic condition that affects how the body processes glucose (sugar), leading to high blood sugar levels. Effective diabetes management involves careful monitoring of blood sugar, medication management, lifestyle adjustments, and regular communication with healthcare providers. Digital solutions have revolutionized this management process by providing tools and insights that empower individuals to take a more active role in their care. The global prevalence of diabetes was steadily increasing, driving the demand for effective and convenient diabetes management solutions. Digital tools offered a way to enhance the management of the condition, leading to better health outcomes.

Market Overview
Forecast Period2025-2029
Market Size 2023USD 14.60 Billion
Market Size 2029USD 24.95 Billion
CAGR 2024-20299.30%
Fastest Growing SegmentContinuous Blood Glucose Monitoring System
Largest MarketNorth America

Rapid advancements in technology, including wearable devices, sensors, mobile apps, and data analytics, were driving the development of innovative digital diabetes management solutions. These technologies provided better insights, real-time monitoring, and personalized recommendations for patients. Growing awareness of diabetes and its management among both patients and healthcare professionals was encouraging the adoption of digital solutions. People were seeking more comprehensive and convenient ways to monitor and manage their condition. The healthcare industry was moving towards personalized medicine, and digital diabetes management solutions played a significant role in delivering tailored care. These solutions could analyze individual data to provide personalized treatment plans and recommendations. Digital solutions collected a wealth of data that could be used to gain insights into diabetes trends, treatment effectiveness, and patient behavior. This data-driven approach enabled healthcare providers to make informed decisions and adjustments to treatment plans.

Key Market Drivers

Technological Advancements

Continuous Glucose Monitoring (CGM) Systems use tiny sensors inserted under the skin to measure glucose levels in the interstitial fluid continuously. These sensors provide real-time data to wearable devices or smartphones, allowing individuals to monitor their glucose levels and trends throughout the day. Advanced CGM systems provide alerts for high and low glucose levels, helping users make timely adjustments to their treatment plans. Many modern insulin pumps are now integrated with CGM systems, creating closed-loop or hybrid closed-loop systems, also known as artificial pancreas systems. These systems automatically adjust insulin delivery based on real-time CGM data, helping to maintain more stable blood sugar levels. Smart insulin pens are equipped with Bluetooth technology to connect with mobile apps. Users can track their insulin doses, monitor injection history, and receive reminders for insulin administration. Some pens also allow users to log carbohydrate intake and physical activity for a more comprehensive picture of diabetes management. Mobile apps have become central to digital diabetes management. These apps enable users to log blood sugar readings, track meals and exercise, set medication reminders, and view trends over time. Some apps also offer personalized recommendations based on data analysis. Advanced data analytics and artificial intelligence (AI) are used to process the vast amount of data generated by digital diabetes management tools. AI algorithms can identify patterns, predict glucose trends, and provide personalized recommendations for insulin dosing, diet adjustments, and activity planning. Telemedicine platforms enable individuals with diabetes to consult healthcare professionals remotely. This is especially important for those in remote areas or unable to travel frequently. Healthcare providers can review glucose data and provide guidance through virtual appointments.

Wearable devices have become more sophisticated, providing not only glucose monitoring but also tracking of physical activity, heart rate, and sleep patterns. These devices offer a holistic view of health that can inform diabetes management decisions. Integration with EHR systems allows healthcare providers to access a patient's diabetes management data in real-time. This integration improves care coordination and enables more informed clinical decisions. Many digital diabetes management solutions incorporate behavioral change techniques, such as reminders, rewards, and social support features. These elements encourage individuals to adopt healthier habits and adhere to their management plans. User interfaces have become more intuitive and user-friendly, catering to a wide range of age groups and technological comfort levels. This enhances overall user experience and engagement. Interoperability standards have improved, allowing different devices and apps to share data seamlessly. This is crucial for holistic diabetes management and collaborative care. This factor will help in the development of Global Digital Diabetes Management Market.

Shift towards Personalized Care

Personalized care tailors' medical treatment and management strategies to individual patients' specific needs, preferences, and circumstances. In the context of diabetes management, this approach has been facilitated and enhanced by digital technologies. Diabetes is a complex condition with varying factors influencing blood sugar levels. Digital diabetes management tools gather data from individuals, such as glucose levels, dietary habits, physical activity, and medication use. By analyzing this data, these tools can offer personalized treatment plans that consider the individual's unique situation. Digital tools provide a wealth of data that can be analyzed to identify patterns, trends, and correlations in an individual's glucose levels. This data-driven approach enables healthcare providers to make more informed decisions and adjustments to treatment plans. Digital diabetes management aligns with the concept of precision medicine, which focuses on tailoring treatments based on a patient's genetic makeup, lifestyle, and environment. This approach can lead to more effective interventions and better outcomes. Continuous glucose monitoring (CGM) systems offer real-time insights into an individual's glucose fluctuations. This allows for immediate feedback and adjustments, helping users to make timely decisions about insulin doses, meals, and activities. Digital diabetes management solutions often offer personalized lifestyle recommendations. For instance, based on an individual's glucose trends, the system might suggest adjustments to diet, exercise routines, and medication timing. Advanced analytics and AI algorithms can predict future glucose trends based on historical data. This enables individuals to anticipate potential high or low blood sugar episodes and take preventive actions.

Digital platforms can provide behavioral nudges and reminders tailored to an individual's specific goals and challenges. This encourages consistent monitoring, medication adherence, and healthier lifestyle choices. Personalized care fosters greater patient engagement and motivation. When individuals see that their management plan is specifically designed for them, they are more likely to take an active role in their health. Personalized recommendations, reminders, and insights improve treatment adherence. Individuals are more likely to stick to their management plans when they feel that these plans are designed with their needs in mind. Traditional diabetes management often involves trial and error to find the right treatment regimen. Digital solutions can streamline this process by providing data-driven guidance, potentially reducing the time and frustration associated with finding effective management strategies. Personalized care through digital solutions takes a holistic view of an individual's health. It considers not only glucose levels but also factors like stress, sleep, and overall well-being, leading to more comprehensive and effective management. Personalized care promotes long-term engagement and sustainability in diabetes management. Customized plans that align with an individual's preferences and needs make it more likely that they will continue managing their condition effectively over time. This factor will pace up the demand of Global Digital Diabetes Management Market.

Improvement in Patient Engagement

Patient engagement refers to the active involvement of individuals in their own healthcare and decision-making process. Digital tools have proven to be effective in enhancing patient engagement, particularly in the context of diabetes management. Digital tools provide individuals with real-time data about their blood sugar levels, medication dosages, and lifestyle factors. This immediate access to information empowers patients to make informed decisions and take timely actions. Patients can actively monitor their glucose levels, track their dietary choices, record physical activity, and log medications. This sense of ownership and responsibility fosters empowerment and self-efficacy. Digital solutions analyze individual data to provide personalized insights and recommendations. These tailored suggestions help patients understand how their choices affect their condition, enabling them to make better choices. Many digital diabetes management tools offer reminders for medication administration, glucose monitoring, exercise, and meal planning. These reminders help patients stay on track and adhere to their treatment plans. Digital platforms allow patients to set health goals and track their progress over time. Achieving milestones and witnessing progress can boost motivation and engagement. Digital solutions provide educational resources, articles, and information about diabetes management. Educated patients are more likely to actively engage in their care and understand the importance of their actions.

Digital tools enable patients to share their data with healthcare providers remotely. This facilitates more productive discussions during appointments and allows providers to offer guidance and adjustments based on current data. Consistent engagement through digital tools fosters long-term commitment to diabetes management. Patients are more likely to sustain their efforts over time when they feel supported and see positive outcomes. Diabetes management can sometimes feel isolated. Digital platforms provide opportunities for patients to connect with others facing similar challenges, fostering a sense of community and support. Digital tools provide immediate feedback on how lifestyle choices affect blood sugar levels. This real-time feedback loop helps patients understand cause-and-effect relationships and make informed adjustments. User-friendly interfaces and mobile apps make it easy for patients to access their data and engage with their diabetes management plan from anywhere, at any time. Engaged patients are more likely to adhere to their prescribed treatment plans, including medication regimens, dietary recommendations, and exercise routines. This factor will accelerate the demand of Global Digital Diabetes Management Market.

Key Market Challenges

Equity and Accessibility

Not everyone has equal access to technology, including smartphones, tablets, and internet connectivity. This digital divide can prevent marginalized populations from benefiting from digital diabetes management solutions. Lower-income individuals may not have the financial means to afford smartphones, wearable devices, or data plans necessary for using digital tools effectively. Rural or remote areas may lack reliable internet connectivity or access to healthcare facilities that can support the use of digital solutions. Digital solutions that are not available in multiple languages or lack user-friendly interfaces can exclude individuals with limited language proficiency or low digital literacy. Older individuals may be less familiar with digital technologies, making it challenging for them to adopt and effectively use digital diabetes management tools. Digital solutions should consider cultural differences and sensitivities in their design and content to ensure relevance and acceptance among diverse populations. Vulnerable populations, including racial and ethnic minorities, may already experience health disparities. Inaccessibility to digital solutions can exacerbate these disparities by limiting their access to advanced care options.

Interoperability Issues

Interoperability refers to the ability of different systems, devices, and applications to communicate, share data, and work together seamlessly. In the context of digital diabetes management, interoperability challenges can hinder the effective exchange of data and collaboration between various tools and platforms. Digital diabetes management involves multiple devices and apps, such as glucose monitors, insulin pumps, mobile apps, and electronic health records. If these systems don't communicate well, data can become fragmented and scattered across different platforms, making it difficult to get a comprehensive view of the patient's health. Incompatibility between devices and platforms can restrict the sharing of vital health data. Healthcare providers may struggle to access complete and up-to-date information, leading to incomplete insights into a patient's condition. When systems are not interoperable, patients may need to manually enter data from one device or app into another. This is time-consuming, prone to errors, and can discourage patients from actively managing their diabetes. Healthcare providers need to seamlessly access and review patient data during appointments. Interoperability challenges can disrupt clinical workflows and hinder efficient patient care. When data from various sources cannot be integrated, valuable insights can be missed. Holistic analysis of data, which might reveal important trends and patterns, becomes difficult. Delayed or inaccessible data can lead to delayed treatment adjustments. In diabetes management, timely responses to changing glucose levels are crucial for avoiding complications.

Key Market Trends

Mobile Apps and Software Solutions

Mobile apps provide individuals with the ability to manage their diabetes directly from their smartphones or tablets. This convenience ensures that users have access to their health data and tools wherever they are, promoting consistent monitoring and management. Mobile apps can integrate with wearable devices and continuous glucose monitors (CGMs) to provide real-time data on blood sugar levels. Users can monitor trends and receive alerts for high or low glucose levels, enabling timely interventions. Apps allow users to log their blood sugar readings, meals, physical activity, and medication dosages. This comprehensive tracking creates a detailed record that can be used to identify patterns and make informed decisions. Many apps use data analytics and artificial intelligence to provide personalized insights and recommendations. These may include suggestions for meal planning, exercise routines, and medication adjustments. Apps can offer behavioral nudges and reminders to encourage users to adhere to their diabetes management plans. These reminders can be for medication doses, blood sugar checks, or even engaging in physical activity. Mobile apps often present data in a visually appealing format, such as graphs and charts. This helps users understand their glucose trends and how their choices impact their condition over time. Apps can offer educational content about diabetes management, helping users better understand their condition and make informed decisions about their lifestyle choices.

Segmental Insights

Product Insights

In 2023, in the Global Digital Diabetes Management Market continuous blood glucose monitoring system segment held the largest share and is predicted to continue expanding over the coming years. Because of its sophisticated features, like connectivity with smart gadgets that act as display devices. Additionally, it can be configured to notify patients in a specific way when specific glucose thresholds are met. The market has been divided into categories based on the product, including apps, continuous blood glucose monitoring systems, smart insulin pens, smart insulin pumps, and smart glucose meters.

Type Insights

In 2023, in the Global Digital Diabetes Management Market Wearable devices segment held the largest revenue share and is predicted to continue expanding over the coming years. Technology breakthroughs like the emergence of artificial intelligence, the introduction of novel technologies like closed-loop pump systems and smart insulin patches, and the expanding use of self-insulin delivery devices in diabetes treatment are largely to blame for the market's expansion. The market has been divided into handheld and wearable devices based on type.

Regional Insights

The North America region dominated the Global Digital Diabetes Management Market in 2023. because numerous digital blood glucose patient monitoring devices have recently received approval and because cutting-edge technology is readily available. For instance, the Omnipod 5 Automated Insulin Delivery System, which interfaces with the Dexcom G6 Continuous Glucose Monitoring (CGM), was declared FDA-cleared by Insulet Corporation in January 2022. With its built-in SmartBolus Calculator, the Omnipod 5 mobile app makes it easier to upload data and monitor patients remotely. In addition, the growing elderly population, and the burden of diabetes from changing lifestyles are anticipated to fuel market expansion.

Key Market Players

Abbott Laboratories Inc.

Medtronic plc

F. Hoffmann-La Roche Ltd.

Bayer AG

Lifescan, Inc.

Dexcom, Inc.

Sanofi SA

Insulet Corporation

Ascensia Diabetes Care Holdings Ag

B Braun Melsungen AG

Report Scope:

In this report, the Global Digital Diabetes Management Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Digital Diabetes Management Market, By Product:

    Smart glucose meter Continuous blood glucose monitoring system Smart insulin pens Smart insulin pumps Apps

Digital diabetes management apps

Weight & diet management apps

Digital Diabetes Management Market, By Type:

    Wearable devices Handheld devices

Digital Diabetes Management Market, By End User:

    Hospitals Home settings Diagnostic centers

Digital Diabetes Management Market, By region:

    North America

United States

Canada

Mexico

    Asia-Pacific

China

India

South Korea

Australia

Japan

    Europe

Germany

France

United Kingdom

Spain

Italy

    South America

Brazil

Argentina

Colombia

    Middle East & Africa

South Africa

Saudi Arabia

UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Digital Diabetes Management Market.

Available Customizations:

Global Digital Diabetes Management Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Impact of COVID-19 on Global Digital Diabetes Management Market

5. Voice of Customer

6. Global Digital Diabetes Management Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Smart Glucose Meter, Continuous blood glucose monitoring system, smart insulin pens, smart insulin pumps, Apps)
    • 6.2.2. By Type (Wearable Devices, Handheld Devices)
    • 6.2.3. By End Use (Hospitals, Home Settings, Diagnostic Centers)
    • 6.2.4. By Region
    • 6.2.5. By Company (2023)
  • 6.3. Market Map

7. Asia Pacific Digital Diabetes Management Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Type
    • 7.2.3. By End Use
    • 7.2.4. By Country
  • 7.3. Asia Pacific: Country Analysis
    • 7.3.1. China Digital Diabetes Management Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Type
        • 7.3.1.2.3. By End Use
    • 7.3.2. India Digital Diabetes Management Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Type
        • 7.3.2.2.3. By End Use
    • 7.3.3. Australia Digital Diabetes Management Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Type
        • 7.3.3.2.3. By End Use
    • 7.3.4. Japan Digital Diabetes Management Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Type
        • 7.3.4.2.3. By End Use
    • 7.3.5. South Korea Digital Diabetes Management Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Type
        • 7.3.5.2.3. By End Use

8. Europe Digital Diabetes Management Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Type
    • 8.2.3. By End Use
    • 8.2.4. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Digital Diabetes Management Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Type
        • 8.3.1.2.3. By End Use
    • 8.3.2. Germany Digital Diabetes Management Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Type
        • 8.3.2.2.3. By End Use
    • 8.3.3. Spain Digital Diabetes Management Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Type
        • 8.3.3.2.3. By End Use
    • 8.3.4. Italy Digital Diabetes Management Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Type
        • 8.3.4.2.3. By End Use
    • 8.3.5. United Kingdom Digital Diabetes Management Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Type
        • 8.3.5.2.3. By End Use

9. North America Digital Diabetes Management Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Type
    • 9.2.3. By End Use
    • 9.2.4. By Country
  • 9.3. North America: Country Analysis
    • 9.3.1. United States Digital Diabetes Management Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Type
        • 9.3.1.2.3. By End Use
    • 9.3.2. Mexico Digital Diabetes Management Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Type
        • 9.3.2.2.3. By End Use
    • 9.3.3. Canada Digital Diabetes Management Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Type
        • 9.3.3.2.3. By End Use

10. South America Digital Diabetes Management Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Type
    • 10.2.3. By End Use
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Digital Diabetes Management Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Type
        • 10.3.1.2.3. By End Use
    • 10.3.2. Argentina Digital Diabetes Management Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Type
        • 10.3.2.2.3. By End Use
    • 10.3.3. Colombia Digital Diabetes Management Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Type
        • 10.3.3.2.3. By End Use

11. Middle East and Africa Digital Diabetes Management Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product
    • 11.2.2. By Type
    • 11.2.3. By End Use
    • 11.2.4. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Digital Diabetes Management Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Product
        • 11.3.1.2.2. By Type
        • 11.3.1.2.3. By End Use
    • 11.3.2. Saudi Arabia Digital Diabetes Management Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Product
        • 11.3.2.2.2. By Type
        • 11.3.2.2.3. By End Use
    • 11.3.3. UAE Digital Diabetes Management Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Product
        • 11.3.3.2.2. By Type
        • 11.3.3.2.3. By End Use

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

  • 13.1. Recent Developments
  • 13.2. Product Launches
  • 13.3. Mergers & Acquisitions

14. Global Digital Diabetes Management Market: SWOT Analysis

15. Porter's Five Forces Analysis

  • 15.1. Competition in the Industry
  • 15.2. Potential of New Entrants
  • 15.3. Power of Suppliers
  • 15.4. Power of Customers
  • 15.5. Threat of Substitute Product

16. PESTLE Analysis

17. Competitive Landscape

  • 17.1. Abbott Laboratories Inc.
    • 17.1.1. Business Overview
    • 17.1.2. Company Snapshot
    • 17.1.3. Products & Services
    • 17.1.4. Financials (In case of listed companies)
    • 17.1.5. Recent Developments
    • 17.1.6. SWOT Analysis
  • 17.2. Medtronic plc
  • 17.3. F. Hoffmann-La Roche Ltd.
  • 17.4. Bayer AG
  • 17.5. Lifescan, Inc.
  • 17.6. Dexcom, Inc.
  • 17.7. Sanofi SA
  • 17.8. Insulet Corporation
  • 17.9. Ascensia Diabetes Care Holdings Ag
  • 17.10. B Braun Melsungen AG

18. Strategic Recommendations

19. About Us & Disclaimer